These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20380886)

  • 1. Doxofylline: a "novofylline".
    Page CP
    Pulm Pharmacol Ther; 2010 Aug; 23(4):231-4. PubMed ID: 20380886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism.
    van Mastbergen J; Jolas T; Allegra L; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):55-61. PubMed ID: 22138191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of doxofylline in asthma and COPD.
    Cazzola M; Matera MG
    Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxofylline, a novofylline inhibits lung inflammation induced by lipopolysacharide in the mouse.
    Riffo-Vasquez Y; Man F; Page CP
    Pulm Pharmacol Ther; 2014 Apr; 27(2):170-8. PubMed ID: 24456641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effect.
    Patel BS; Kugel MJ; Baehring G; Ammit AJ
    Pulm Pharmacol Ther; 2017 Aug; 45():34-39. PubMed ID: 28414142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxofylline is not just another theophylline!
    Matera MG; Page C; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3487-3493. PubMed ID: 29255355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline in chronic obstructive pulmonary disease: new horizons.
    Barnes PJ
    Proc Am Thorac Soc; 2005; 2(4):334-9; discussion 340-1. PubMed ID: 16267358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Dini FL; Cogo R
    Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Theophylline in treatment of bronchial obstructive diseases].
    Rogala B
    Wiad Lek; 1998; 51(3-4):117-21. PubMed ID: 9658984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid sparing effects of doxofylline.
    Riffo-Vasquez Y; Venkatasamy R; Page CP
    Pulm Pharmacol Ther; 2018 Feb; 48():1-4. PubMed ID: 29031617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
    Lal D; Manocha S; Ray A; Vijayan VK; Kumar R
    J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
    Cazzola M; Calzetta L; Barnes PJ; Criner GJ; Martinez FJ; Papi A; Gabriella Matera M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29720510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
    Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
    Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of doxofylline in COPD: A pairwise meta-analysis.
    Cazzola M; Calzetta L; Rogliani P; Page C; Matera MG
    Pulm Pharmacol Ther; 2018 Aug; 51():1-9. PubMed ID: 29705620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on doxofylline injection in treatment of children with acute asthma attacks].
    Zhang JX; Lin HQ; Chen JS
    Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):143-4. PubMed ID: 15059495
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
    Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
    Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
    Calzetta L; Matera MG; Goldstein MF; Fairweather WR; Howard WW; Cazzola M; Rogliani P
    Pulm Pharmacol Ther; 2020 Feb; 60():101883. PubMed ID: 31884206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of theophylline and doxofylline on airway responsiveness in beagles].
    Sugeta A; Imai T; Idaira K; Horikoshi S; Okamoto M; Adachi M
    Arerugi; 1997 Jan; 46(1):7-15. PubMed ID: 9078607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthines and Phosphodiesterase Inhibitors.
    Spina D; Page CP
    Handb Exp Pharmacol; 2017; 237():63-91. PubMed ID: 27844172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxofylline, an adenosine-nonblocking xanthine, does not induce cardiostimulant effects.
    Cirillo R; Grossi E; Franzone JS
    Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):21-34. PubMed ID: 2781149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.